DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors

Core Insights - Diagnos Inc. has appointed Dr. Philippe Couillard as Chairman of the Board, which is seen as a strategic move to enhance the company's governance and growth during a pivotal time for its AI-enabled product CARA [1][3] Company Overview - Diagnos Inc. is a publicly traded Canadian corporation focused on the early detection of critical eye-related health issues using advanced AI technology [4] - The company aims to improve diagnostic accuracy, streamline workflows, and enhance patient outcomes globally [4] Leadership Background - Dr. Philippe Couillard is a seasoned business advisor and neurosurgeon with significant public service experience, having served as Minister of Health and Social Services and Premier of Quebec [2] - He joined the Board of Diagnos on April 1, 2024, and his expertise is expected to contribute to the company's success in major markets [2][4] Market Expansion - The company is actively pursuing regulatory licenses and approvals for its flagship product CARA in Canada, the United States, and Saudi Arabia [3] - The progress in these applications is described as advancing at a fast pace, indicating a strong potential for market entry [3]